CalciMedica Inc.

CALC | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.82

-$0.04 (-2.15%)

Sep 22, 2026, 11:51 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $5.86M

Enterprise Value $-12.76M

Beta 1.12

Average Volume 204.21K

Shares Outstanding (Diluted) 3.42M

Shares Change YoY 14.04%

Institutional Ownership 7.31%

Exchange NASDAQ

ISIN US38942Q3011

Price Performance

Price Change 1M -35.9%

Price Change 3M -53.7%

Price Change 6M -35.4%

Price Change YTD -94.5%

Price Change 1Y -88.5%

Price Change 3Y -85.9%

Price Change 5Y -92.6%

1M CAGR (ann.) -45.9%

1Y CAGR (ann.) -88.4%

5Y CAGR (ann.) N/A

All-Time CAGR -56.9%

Valuation

PE Ratio -0.27

Forward PE N/A

PEG Ratio 0.07

Forward PEG -0.00

PS Ratio N/A

Forward PS 0.90

PB Ratio 1.06

P/FCF Ratio -0.31

P/Adj. FCF Ratio -0.27

P/OCF Ratio -0.33

EV/Sales N/A

EV/EBIT 0.64

EV/EBITDA 0.64

EV/FCF 0.67

Earnings Yield -373.7%

FCF Yield -326.5%

Adj. FCF Yield -366.6%

Financial Health

Net Cash $18.62M

Total Debt $0

Cash & Short-Term Investments $18.62M

Total Assets $19.5M

Current Ratio 5.58

Quick Ratio 5.58

Debt / Equity Ratio 0.00

Debt / EBITDA -0.00

Debt / FCF -0.00

OCF / Debt N/A

Interest Coverage -15.16

Altman Z-Score -15.92

Piotroski F-Score 4

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -12.3%

Returns

Return on Assets -108.9%

Return on Equity 3398.4%

Return on Invested Capital -122.6%

Return on Capital Employed -122.6%

Return on Tangible Assets -108.9%

Historical Growth (CAGR)

Revenue CAGR 3Y N/A

Revenue CAGR 5Y N/A

Revenue CAGR 10Y N/A

EPS CAGR 3Y 15.1%

EPS CAGR 5Y 61.7%

EPS CAGR 10Y N/A

FCF CAGR 3Y 1.4%

FCF CAGR 5Y 2.9%

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Buy

Analyst Count 3

EPS Growth Next 3Y 27.5%

Revenue Growth Next 3Y N/A

Earnings Date Nov 10, 2026

EPS Estimate (next Q) -$1.27

EPS Growth Est (next Q) -51.0%

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $266

Price Target Upside 14201.1%

Cash Flow

Operating Cash Flow $-19.11M

Free Cash Flow $-19.12M

Adj. Free Cash Flow $-21.47M

FCF Per Share -$5.59

OCF Per Share -$5.59

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $-7K

Operating Income $-19.63M

EBITDA $-19.91M

Net Income $-21.24M

EPS (Diluted) -$6.95

Revenue / Employee N/A

Profit / Employee $-1.42M

Employees 15